Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
07/2004
07/08/2004WO2003021225A3 Method for classification of anti-psychotic drugs
07/08/2004WO2003006679A8 52908, a human potassium channel, and uses thereof
07/08/2004WO2002097060A3 Carbohydrate-associated proteins
07/08/2004WO2002095058A3 Emission ratiometric indicators of phosphorylation
07/08/2004WO2002090926A3 Dose response-based methods for identifying receptors having alterations in signaling
07/08/2004WO2002081655A3 Fusion protein construct and method for inducing hiv-specific serum igg and secretory iga antibodies in-vivo
07/08/2004WO2002060914A8 Identification of small rnas and orfs form e. coli as mediators of cell and intercell regulation
07/08/2004WO2001022916A3 Novel hev antigenic peptide and methods
07/08/2004US20040133949 Rice-derived high expression polypeptide chain elongation factor promoter and method of using the same
07/08/2004US20040133948 Dwf7 mutants
07/08/2004US20040133945 Corn root preferential promoters and uses thereof
07/08/2004US20040133942 Comprises insecticidal protein against lepidopteran insect pests; biological pest control and tissue engineering
07/08/2004US20040133934 Transgenic animals that produce human hemoglobin
07/08/2004US20040133933 Medane genes and proteins
07/08/2004US20040133932 Genetically engineered mammal for use as bioreactor in expression of heterologous proteins and blood coagulation factors in milk
07/08/2004US20040133930 Production of high levels of transgenic factor ix without gene rescue, and its therapeutic uses
07/08/2004US20040132987 Comprises nucleotide sequences coding cysteine rich polypeptide for use in identifying modulators for prevention and diagnosis of atherosclerosis and fibrotic diseases
07/08/2004US20040132983 Comprises nucleotide sequences coding microbial polypeptide for use as diagnostic and therapeutic tools in treatment and prevention of microbial infection
07/08/2004US20040132980 Humanized anti-CCR2 antibodies and methods of use therefor
07/08/2004US20040132978 Method for purifying and recovering silk proteins in soluble form and uses thereof
07/08/2004US20040132977 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
07/08/2004US20040132976 Colon specific genes and proteins
07/08/2004US20040132975 Bacillus chimeric crystal protein with enhanced insecticidal for use in generating and propagating insect resistant plants; biological control agents; pest control
07/08/2004US20040132974 Cell adhesion polypeptide for use tools in diagnosis, prevention and treatment of cardiovascular, cell proliferative, ischemic, restenotic, blood and gastrointestinal disorders
07/08/2004US20040132973 for gene therapy and vaccination; enzyme-linked immunosorbent assay (ELISA); kits; genetic engineering
07/08/2004US20040132972 Tri-hybrid melanoma antigen
07/08/2004US20040132971 Receptor activator of nuclear factor-kappaBeta ligand (RANKL) for use in the identification of modulators for treatment and prevention of bone disorders
07/08/2004US20040132970 Microbiocide comprising nuclear localization sequences for use as drug delivery tools; antitumor agents; gene expression inhibition
07/08/2004US20040132969 Amino acid sequences for use in the prevention and treatment of cell proliferative, arthritic, cardiovascular and skin disorders; antitumor agents; antiscarring agents; wound healing agents
07/08/2004US20040132968 Novel bag proteins and nucleic acid molecules encoding them
07/08/2004US20040132967 Mimetic peptide comprised of terminal amino acid sequences of surfactant protein b (SP-B) and dipalmitoylphosphatidylcholine for use in treatment of respiratory system disorder
07/08/2004US20040132957 Precursors of silk-like materials, silk-like materials and processes for producing both
07/08/2004US20040132783 Method of examining effect of angiogenesis inhibitors mediated by the inhibition of integrin expression
07/08/2004US20040132685 Immunostimulatory nucleic acid
07/08/2004US20040132683 Expression of exogenous polynucleotide sequences in a vertebrate
07/08/2004US20040132678 Recombinant double-stranded RNA phage, and use of the same
07/08/2004US20040132674 Regulatory sequence for the specific expression in dendritic cells and uses thereof
07/08/2004US20040132665 Small survival-promoting/immunomodulatory peptide for treatment of brain damage, neurodegenerative disorders, and inflammatory disorders
07/08/2004US20040132663 Nervous system, cardiovascular, and psychological disorder treatment; anticonvulsant agents, neuroprotectants, analgesics; headaches; snail venom
07/08/2004US20040132661 Therapeutic method for treating bone formation diseases
07/08/2004US20040132660 PRO256 polypeptide; wound healing and anticarcinogenic agents; cardiovascular disorders, atherosclerosis, and cardiac hypertrophy treatment
07/08/2004US20040132659 Contortrostatin CN and methods for its use in preventing metastasis and other conditions
07/08/2004US20040132658 Administering polypeptide with extracellular region having deletion, replacement or other mutation and an amino acid sequence comprising Phe-Asp-Pro-Pro-Pro-Phe to inhibit transmission of a costimulatory signal of lymphocytes
07/08/2004US20040132654 Increased content of high molecular weight multimers; hemophilia and blood disorder treatment
07/08/2004US20040132652 Liposome associated to Neisseria meningitis polypeptide fragments or DNA fragments; prevention or diagnosis of infection
07/08/2004US20040132651 Administering modulating agent comprising histidine-alanine-valine tripeptide to treat demyelinating nervous system disorders such as multiple sclerosis; inhibits cadherin-mediated cell adhesion
07/08/2004US20040132648 Remedies and/or preventives for conformational diseases
07/08/2004US20040132647 Amidated glucagon-like peptide-1
07/08/2004US20040132646 Identification of a novel glutamine transporter
07/08/2004US20040132644 Composition and method for treating diabetes
07/08/2004US20040132641 Fas peptide mimetics and uses thereof
07/08/2004US20040132638 Administering modified hemoglobins comprising nitrosylhemoglobin, nitrosyl-heme, metal substituted heme iron, or nitrosyl-porphyrin; vasodilation; anticoagulants; synthetic blood
07/08/2004US20040132617 Having His-Phe-Asp-Leu-Ser-Gly motif; plant derived; more effective on monocotyledon than dicotyledon cells; paper and textile processing
07/08/2004US20040132191 Yeasts transformed by genes enhancing their cold stress tolerance
07/08/2004US20040132190 Comprises genetically engineered adenoviral coding therapeutic agents as marker protein for use as gene transfer/drug delivery tool in cardiac diagnostic catheterization
07/08/2004US20040132188 Mixture comprising modified peptides for use as facilatory tool in gene and protein transfer into cells; gene therapy; drug delivery
07/08/2004US20040132187 Methods and compositions for measuring ion channel conductance
07/08/2004US20040132182 Use of EDG2 receptor in an animal model of heart failure
07/08/2004US20040132180 Expression vector coding reporter protein for use as diagnostic tool in gene transformation analysis
07/08/2004US20040132178 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
07/08/2004US20040132163 Biological materials and uses thereof
07/08/2004US20040132162 Chimeric papillomavirus-like particles
07/08/2004US20040132160 Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells
07/08/2004US20040132143 using the hyaluronate or chondroitin or heparin/heparosan synthases from Pasteurella, in order to create a variety of glycosaminoglycan oligosaccharides having a natural or chimeric or hybrid sugar structure with a targeted size
07/08/2004US20040132139 Comprises nucleotide sequences coding protein with antiproliferative and viricidal activity for use in treatment and prevention of cancer, nervous system, bone and autoimmune disorders
07/08/2004US20040132138 Nucleic acid encoding recombinant salmon calcitonin, expression vector thereof, and method for producing recombinant salmon calcitonin therewith
07/08/2004US20040132137 Thyroid glycoprotein horomone for treatment and prevention of hyperthyroidism and graves' disease
07/08/2004US20040132136 Comprises viricidal polypeptide for prevention and treatment of viral diseases; antiproliferative agents
07/08/2004US20040132135 Comprises nucleotide sequences coding transport protein for use as tools in the delivery of drugs to liver; tissue directed therapy
07/08/2004US20040132134 Identification of a novel bitter taste receptor, T2R76
07/08/2004US20040132132 Isolating, transforming and expression of vaccinia viral antigen sequences in bacteria for use as tool in development of serodiagnostic agents and vaccines
07/08/2004US20040132121 Method of identifying antibacterial compounds
07/08/2004US20040132120 Cell regulatory genes, encoded products, and uses related thereto
07/08/2004US20040132117 Immunoassay and diagnostic reagent for malaria
07/08/2004US20040132108 Using mimetic peptide to identify modulators for treatment and prevention of cell proliferative and ischemic injuries/disorders
07/08/2004US20040132107 Generation of transgenic insect cells for use as diagnostic tools in monitoring interactions between cell membrane protein and ligands
07/08/2004US20040132105 by blotting assays and affinity chromatography of activated platelets or activated endothelial cell (labeled HL-60 cell) extracts
07/08/2004US20040132094 Combinatorial libraries of proteins having the scaffold structure of c-type lectinlike domains
07/08/2004US20040132093 Comprises cytokine receptor fusion protein for use in indentifying modulators for treatment of bone disorders
07/08/2004US20040132088 Expression vectors encoding epitopes of target-associated antigens and methods for their design
07/08/2004US20040132085 Mammalian cell membrane proteins; related reagents
07/08/2004US20040132077 Recombinant polypeptides for diagnosing infection with Trypanosoma cruzi
07/08/2004US20040132076 Identifying differentially expressed nucleotide sequences in two different tissue samples; gene expression analysis
07/08/2004US20040132075 Comprises nucleotide sequences coding mammalian taste-cell-specific G protein-coupled receptors for use in identifying agents which modify chemosensory taste transduction; sweetness and food processing
07/08/2004US20040132073 Novel G protein-coupled receptor protein, its DNA and ligand thereof
07/08/2004US20040132071 Method for examining the caries risk
07/08/2004US20040132067 Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
07/08/2004US20040132065 Promoter sequences for corticotropin releasing-factor binding protein and use thereof
07/08/2004US20040132060 Comprises nucleotide sequences coding hepatic nuclear factor (HNF) for use in diagnosis, treatment and prevention of maturity onset of diabetes of the young (MODY)
07/08/2004US20040132058 NPC1L1 (NPC3) and methods of use thereof
07/08/2004US20040132057 Tumor necrosis related receptor,TR7
07/08/2004US20040132052 Comprises nucleotide sequences coding cell signaling glycoprotein for use in screening and identifying antagonist of cancer; tumor diagnosis and treatment; antitumor agents; drug screening
07/08/2004US20040132045 Comprises g-protein coupled receptors for use in treatment and prevention of obesity
07/08/2004US20040132043 Proteins Associated with cell growth, differentiation, and death
07/08/2004US20040132038 Membrane protein for use as diagnostic tool in the detection and prevention of cell proliferative, cardiovascular, skin, nervous system, respiratory and metabolic disorders
07/08/2004US20040132035 Using suppression subtractive hybridization to identify differentially expressed genes associated with cardiovascular disorder; vasodilation dysfunction
07/08/2004US20040132030 Identification of neuroblastoma tumor suppressor genes
07/08/2004US20040132028 Collection of repeat proteins comprising repeat modules
07/08/2004US20040132022 Comprises nucleotide sequences coding growth factor for treatment and prevention of aberrations in cellular growth and differentiation; cancer diagnosis and treatment; antitumor agents
07/08/2004US20040132021 Using presence of genetic variation in van buchem-sclerosteosis disease region to identify disorders resulting in either net excess bone formation or insufficient bone formation in humans; allelicvariation and bone disorders